OS Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.97	5.53	0.04	0.17	0.08	1.23
Cash & Short-Term Investments	2.97	5.53	0.04	0.17	0.08	1.23
Cash Growth	2864.16%	14095.08%	-77.27%	112.26%	-93.45%	-
Receivables	-	-	-	0	0.23	0.43
Other Current Assets	0.02	-	0.75	0.32	0	0.01
Total Current Assets	4.1	5.53	0.79	0.5	0.31	1.68
Property, Plant & Equipment	0	0.01	0.01	0.01	0.01	0
Total Assets	4.25	5.54	0.8	0.51	0.33	1.68
Accounts Payable	1.62	1.66	2.72	1.23	0.86	0
Accrued Expenses	0.36	0.62	2.33	1.66	0.93	1.23
Short-Term Debt	-	-	2.48	-	-	-
Current Portion of Long-Term Debt	-	-	12.13	-	-	-
Other Current Liabilities	1.56	2.35	5.05	3.26	1.71	0.87
Total Current Liabilities	3.54	4.63	24.71	6.15	3.5	2.1
Long-Term Debt	-	-	-	10.35	7.07	5.9
Long-Term Unearned Revenue	0.1	0.1	0.1	0.1	0.1	-
Other Long-Term Liabilities	-	-	-	1.47	1.11	-
Total Liabilities	3.64	4.73	24.81	18.07	11.78	8
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	38.1	35.14	5.5	4.03	3.76	-
Retained Earnings	-42.31	-40.4	-29.52	-21.6	-15.22	-6.34
Total Common Equity	-4.19	-5.24	-24.02	-17.56	-11.45	-6.33
Shareholders' Equity	0.61	0.81	-24.02	-17.56	-11.45	-6.33
Total Liabilities & Equity	4.25	5.54	0.8	0.51	0.33	1.68
Total Debt	-	-	14.61	10.35	7.07	5.9
Net Cash (Debt)	2.97	5.53	-14.57	-10.18	-6.99	-4.67
Net Cash Per Share	0.18	0.45	-2.68	-1.02	-0.70	-0.55
Filing Date Shares Outstanding	28.1	21.66	11.98	10.72	10.72	8.42
Total Common Shares Outstanding	21.35	20.87	10.68	9.98	9.98	8.42
Working Capital	0.56	0.91	-23.92	-5.65	-3.18	-0.43
Book Value Per Share	-0.20	-0.25	-2.25	-1.76	-1.15	-0.75
Tangible Book Value	-4.19	-5.24	-24.02	-17.56	-11.45	-6.33
Tangible Book Value Per Share	-0.20	-0.25	-2.25	-1.76	-1.15	-0.75

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q